A novel intravitreal axitinib hydrogel demonstrated durable disease control in patients with treatment-naive neovascular age-related macular degeneration (AMD), with superior maintenance of visual ...

For decades, the management of diabetic retinopathy (DR) has consisted mainly of optimizing metabolic control (blood glucose, pressure and lipids) and routine surveillance as preventive strategies, ...

Detailed price information for Theriva Biologics Inc (TOVX-A) from The Globe and Mail including charting and trades.

Director Francesco Calabrò of the Ophthalmology Unit at Azienda Ospedaliera dei Colli, together with his team nurses Angela ...

FRONT-2 global enrollment completed approximately 4 months ahead of initial projections4FRONT-2 over-enrolled (anticipated N>500), with final patient randomization expected in Q3 2026, reflecting ...